Enhanced Product Stability
Esterification significantly protects Lycopene from oxidation and degradation during formulation and storage.
Lycopene Ester is a highly stable, lipophilic derivative of Lycopene, offering enhanced bioavailability and color stability compared to free Lycopene. It is widely used in functional foods, supplements, and cosmetics. Production faces challenges: extraction from natural sources like tomatoes yields low extraction amount in tomatoes and results in complex mixtures. Furthermore, Lycopene itself has poor stability in chemical synthesis and processing, prone to degradation by light and heat. Biosynthesis in engineered yeast offers a sustainable, highly stable, and cost-effective source.
CD Biosynsis offers a synthetic biology service focused on the high-titer production of Lycopene Ester in Saccharomyces cerevisiae. Our core strategy involves modification of yeast carotenoid pathway . We engineer the upstream mevalonate (MVA) pathway to dramatically increase the supply of the precursor Farnesyl Diphosphate (FPP) , and then introduce the bacterial gene cluster for Lycopene synthesis (CrtE, CrtB, CrtI). Crucially, this is coupled with the heterologous expression of ester synthase —introducing a Lycopene Acyltransferase gene to efficiently convert the newly synthesized Lycopene into the highly stable Lycopene Ester (e.g., lycopene oleate or palmitate). This integrated approach aims to deliver a high-yield, specific, and intrinsically stable Lycopene Ester product.
Get a QuoteDeveloping a competitive Lycopene Ester bioproduction route faces these key limitations:
A successful solution must overcome upstream supply limitations and implement the specific enzymatic step for esterification and stabilization.
CD Biosynsis utilizes advanced synthetic biology to engineer S. cerevisiae for high-yield Lycopene Ester production:
Modification of Yeast Carotenoid Pathway
We overexpress key rate-limiting enzymes (HMG-CoA reductase) and downregulate competing pathways (ergosterol synthesis) to maximize the flux toward FPP and Lycopene.
Heterologous Expression of Ester Synthase
We introduce and optimize the expression of a Lycopene Acyltransferase from a suitable host (e.g., bacteria or fungi) to efficiently perform the final esterification step.
Lycopene Synthesis Gene Cluster Optimization
We co-express and optimize the balance of the CrtE, CrtB, and CrtI genes needed to convert FPP into the Lycopene backbone.
Lipid Metabolism and Storage Enhancement
We engineer the host to increase neutral lipid storage (lipid droplets) , which serve as an intracellular sink for the hydrophobic ester product, boosting accumulation.
This systematic approach is focused on maximizing the carbon flux toward the carotenoid pathway and adding the final stabilization step.
Our Lycopene Ester engineering service is dedicated to pursuing the following production goals:
Enhanced Product Stability
Esterification significantly protects Lycopene from oxidation and degradation during formulation and storage.
High Specific Titer
Upstream pathway enhancement leads to high Lycopene Ester accumulation that far exceeds levels achievable in natural sources.
Sustainable Production Route
Fermentation utilizes renewable sugar feedstock instead of relying on inefficient agricultural extraction methods.
Simplified Extraction
The product's hydrophobic nature allows it to be stored efficiently in lipid droplets , facilitating simpler organic solvent extraction.
Increased Bioavailability
The ester form is highly lipophilic, which is crucial for efficient absorption in the human gut.
We provide a specialized metabolic engineering platform aimed at optimizing the yield and stability of Lycopene Ester compounds.
Our Lycopene Ester strain engineering service follows a rigorous, multi-stage research workflow:
Technical communication is maintained throughout the process, focusing on timely feedback regarding yield and specific ester structure.
Explore the potential for a high-stability, sustainable Lycopene Ester supply. CD Biosynsis provides customized strain engineering solutions:
Why is Lycopene Ester more stable than Lycopene?
Lycopene Ester is formed when a fatty acid chain is attached to the Lycopene molecule, making it less polar. This modification reduces the molecule's exposure to free radicals and inhibits Z-E isomerization, significantly increasing stability against oxidation and light.
What is the role of the MVA pathway?
The Mevalonate (MVA) pathway is the central metabolic route in yeast that synthesizes FPP (Farnesyl Diphosphate), the C15 precursor that is dimerized and elongated to form the C40 Lycopene backbone.
How do you control the type of ester produced?
The type of ester produced depends on the fatty acid pool available inside the cell and the specificity of the introduced Acyltransferase. We can genetically modify the host's fatty acid synthesis to bias the pool toward specific fatty acids (e.g., oleic acid) to obtain the desired ester form.
What are the Crt genes?
Crt genes (CrtE, CrtB, CrtI) are the bacterial genes that constitute the core Lycopene synthesis pathway. CrtE forms GGPP, CrtB dimerizes GGPP into Phytoene, and CrtI performs the desaturation steps to form Lycopene.
What is the estimated project timeline?
A project involving complex multi-gene cluster integration, MVA pathway modification, and specific enzyme expression typically requires 22-26 weeks for final strain delivery and comprehensive performance validation.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.